Physician profile
Adhir Shroff
NPI 1285672196
$110,658.30
in general payments reported to CMS, 2019-2025
29 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $28K · 2021: $6,178 · 2022: $8,448 · 2023: $7,076 · 2024: $9,948 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,638 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Food and Beverage: $2,211 · Travel and Lodging: $1,578 · Education: $62.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,637.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Food and Beverage | $2,210.70 |
| Travel and Lodging | $1,578.20 |
| Education | $62.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $22,220.53 | 2019-2020 | |
| Terumo Medical Corporation | $16,581.59 | 2019-2025 | Navicross, Glidesheath Slender |
| Abbott Laboratories | $13,684.85 | 2019-2024 | Diamondback Coronary, Coroflow, Optis |
| Cardiovascular Systems INC. | $12,675.54 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $11,264.56 | 2019-2025 | Micra, Symplicity G3, In.Pact Admiral |
| Abiomed | $11,127.92 | 2019-2023 | Impella |
| Shockwave Medical, INC | $9,176.73 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6,557.09 | 2019-2020 | |
| Cardinal Health 200 LLC | $2,528.61 | 2020-2021 | |
| Merit Medical Systems INC | $1,679.87 | 2022-2024 | Prelude Introducers, Mba Hemostasis Valve |
| Zoll Circulation INC | $1,350.00 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Biotronik INC. | $586.41 | 2019-2022 | |
| Inari Medical, INC. | $315.41 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $156.56 | 2025 | Flowtriever |
| Asahi Intecc USA, INC. | $154.96 | 2025 | Asahi Coronary Wires |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $127.75 | 2024 | |
| Cardiva Medical, INC. | $101.30 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $62.01 | 2023 | Kengreal |
| Surmodics, INC. | $45.32 | 2022-2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Astrazeneca Pharmaceuticals LP | $44.87 | 2019-2021 | |
| Boston Scientific Corporation | $40.53 | 2019-2022 | |
| Opsens INC. | $37.19 | 2022 | |
| Penumbra, INC. | $32.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.23 | 2023 | Xarelto |
| Teleflex LLC | $26.78 | 2025 | Vascband |
| Edwards Lifesciences Corporation | $20.28 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cordis US Corp. | $16.70 | 2024 | Mynx Venous Vcd |
| Novartis Pharmaceuticals Corporation | $14.33 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adhir Shroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.